Authors: Jernigan, JA Stephens, DS Ashford, DA Omenaca, C Topiel, MS Galbraith, M Tapper, M Fisk, TL Zaki, S Popovic, T Meyer, RF Quinn, CP Harper, SA Fridkin, SK Sejvar, JJ Shepard, CW McConnell, M Guarner, J Shieh, WJ Malecki, JM Gerberding, JL Hughes, JM Perkins, BA

Citation: Ja. Jernigan et al., Bioterrorism-related inhalational anthrax: The first 10 cases reported in the United States, EM INFECT D, 7(6), 2001, pp. 933-944

Authors: Purkiss, JR Friis, LM Doward, S Quinn, CP

Citation: Jr. Purkiss et al., Clostridium botulinum neurotoxins act with a wide range of potencies on SH-SY5Y human neuroblastoma cells, NEUROTOXICO, 22(4), 2001, pp. 447-453

Authors: Chaddock, JA Purkiss, JR Duggan, MJ Quinn, CP Shone, CC Foster, KA

Citation: Ja. Chaddock et al., A conjugate composed of nerve growth factor coupled to a non-toxic derivative of Clostridium botulinum neurotoxin type A can inhibit neurotransmitterrelease in vitro, GROW FACTOR, 18(2), 2000, pp. 147-155

Authors: Chaddock, JA Purkiss, JR Friis, LM Broadbridge, JD Duggan, MJ Fooks, SJ Shone, CC Quinn, CP Foster, KA

Citation: Ja. Chaddock et al., Inhibition of vesicular secretion in both neuronal and nonneuronal cells by a retargeted endopeptidase derivative of Clostridium botulinum neurotoxintype A, INFEC IMMUN, 68(5), 2000, pp. 2587-2593

Authors: Bowen, JE Quinn, CP

Citation: Je. Bowen et Cp. Quinn, The native virulence plasmid combination affects the segregational stability of a theta-replicating shuttle vector in Bacillus anthracis var. New Hampshire, J APPL MICR, 87(2), 1999, pp. 270-278